Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Manro JR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Li Y; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., Amaladas N; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., O'Mahony M; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Inigo I; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., Li Q; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., Rasmussen ER; Lilly Research Laboratories, Eli Lilly and Company, New York City, New York, United States of America., Brahmachary M; Lilly Research Laboratories, Eli Lilly and Company, New York City, New York, United States of America., Doman TN; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Hall G; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., Kalos M; Lilly Research Laboratories, Eli Lilly and Company, New York City, New York, United States of America., Novosiadly R; Lilly Research Laboratories, Eli Lilly and Company, New York City, New York, United States of America., Puig O; Lilly Oncology, Alexandria Center for Life Sciences, New York City, New York, United States of America., Pytowski B; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America., Schaer DA; Loxo Oncology at Lilly, Eli Lilly and Company, New York City, New York, United States of America.
Publikováno v:
PloS one [PLoS One] 2022 Jul 18; Vol. 17 (7), pp. e0268244. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).
Autor:
Köhler J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. pasi_janne@dfci.harvard.edu jens_kohler@dfci.harvard.edu., Zhao Y; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Li J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tiv HL; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Knott AR; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Wilkens MK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Soroko KM; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Lin M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Ambrogio C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Center, University of Torino, Torino, Italy., Musteanu M; Experimental Oncology, Molecular Oncology Program, CNIO, Madrid, Spain.; Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Complutense University of Madrid, Spain., Ogino A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Choi J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Bahcall M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Bertram AA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Chambers ES; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bhagwat SV; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Tiu RV; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Jänne PA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. pasi_janne@dfci.harvard.edu jens_kohler@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Apr; Vol. 20 (4), pp. 641-654. Date of Electronic Publication: 2021 Feb 03.
Autor:
Du J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana. du_jian@lilly.com., Yan L; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Torres R; Eli Lilly and Company, Alcobendas (Madrid), Spain., Gong X; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bian H; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Marugán C; Eli Lilly and Company, Alcobendas (Madrid), Spain., Boehnke K; Eli Lilly and Company, Alcobendas (Madrid), Spain., Baquero C; Eli Lilly and Company, Alcobendas (Madrid), Spain., Hui YH; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Chapman SC; Eli Lilly and Company, Windlesham, United Kingdom., Yang Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Zeng Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bogner SM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Foreman RT; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Capen A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Van Horn RD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Barnard DS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Dempsey JA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Beckmann RP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Marshall MS; Ped-Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Chio LC; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Qian Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Webster YW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Aggarwal A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Chu S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bhattachar S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Stancato LF; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Dowless MS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Iversen PW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Walgren JL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Halstead BW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Dieter MZ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Martinez R; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Bhagwat SV; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Kreklau EL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Lallena MJ; Eli Lilly and Company, Alcobendas (Madrid), Spain., Ye XS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Patel BKR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Reinhard C; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Plowman GD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Barda DA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Henry JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Buchanan SG; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Campbell RM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2019 Dec; Vol. 18 (12), pp. 2207-2219. Date of Electronic Publication: 2019 Sep 17.
Autor:
Schaer DA; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Geeganage S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Amaladas N; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Lu ZH; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Rasmussen ER; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sonyi A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chin D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Capen A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Li Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Meyer CM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Jones BD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Huang X; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Luo S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Carpenito C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Roth KD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Nikolayev A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Tan B; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Brahmachary M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chodavarapu K; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Dorsey FC; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Doman TN; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Donoho GP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Surguladze D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Hall GE; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Kalos M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. ruslan.novosiadly@bms.com mkalos@arsenalbio.com., Novosiadly RD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. ruslan.novosiadly@bms.com mkalos@arsenalbio.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 01; Vol. 25 (23), pp. 7175-7188. Date of Electronic Publication: 2019 Aug 13.
Autor:
Yan SB; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA. s.betty_yan@lilly.com., Um SL; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Peek VL; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Stephens JR; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Zeng W; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Konicek BW; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Liu L; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Wacheck V; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA., Walgren RA; Lilly Research Laboratories, Eli Lilly and Company, DC0522, 307 E. McCarty Street, Indianapolis, IN, 46285, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2018 Aug; Vol. 36 (4), pp. 536-544. Date of Electronic Publication: 2017 Nov 29.
Autor:
Holmgaard RB; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Schaer DA; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Li Y; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Castaneda SP; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Murphy MY; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Xu X; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Inigo I; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Dobkin J; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Manro JR; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Eli Lilly and Company 46285 Indianapolis IN USA., Iversen PW; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Eli Lilly and Company 46285 Indianapolis IN USA., Surguladze D; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Hall GE; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Novosiadly RD; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Benhadji KA; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Plowman GD; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA., Kalos M; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA.; Janssen Pharmaceutical Companies of Johnson and Johnson Spring House PA USA., Driscoll KE; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street New York USA Driscoll_kyla@lilly.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Jun 04; Vol. 6 (1), pp. 47. Date of Electronic Publication: 2018 Jun 04.
Autor:
Yingling JM; Idera Pharmaceuticals, Inc., Cambridge, Massachusetts, USA., McMillen WT; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Yan L; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Huang H; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA., Sawyer JS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Graff J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Clawson DK; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Britt KS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Anderson BD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Beight DW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Desaiah D; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Lahn MM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Benhadji KA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Lallena MJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Holmgaard RB; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Xu X; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Zhang F; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Manro JR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Iversen PW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Iyer CV; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Brekken RA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA., Kalos MD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA., Driscoll KE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN and New York, NY, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Dec 31; Vol. 9 (6), pp. 6659-6677. Date of Electronic Publication: 2017 Dec 31 (Print Publication: 2018).
Autor:
Atkinson JM; Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Rank KB; Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Zeng Y; Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Capen A; Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Yadav V; Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Manro JR; Statistics Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Engler TA; Discovery Chemistry Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America., Chedid M; Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Apr 27; Vol. 10 (4), pp. e0125028. Date of Electronic Publication: 2015 Apr 27 (Print Publication: 2015).